Pharmsville Co., Ltd. (KOSDAQ: 318010)

Pharmsville Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,324	5,470	18,210	14,031	9,557	6,692
Short-Term Investments	-	3,000	3,000	22,204	1,221	19,610
Trading Asset Securities	33,921	31,077	21,625	5,499	25,519	12,840
Cash & Short-Term Investments	39,245	39,546	42,835	41,735	36,297	39,142
Cash Growth	-0.94%	-7.68%	2.64%	14.98%	-7.27%	173.45%
Accounts Receivable	1,255	1,176	1,942	2,430	1,934	2,074
Other Receivables	77.83	99.53	162.14	55.48	93.07	188.03
Receivables	1,333	1,275	2,104	2,485	2,027	2,262
Inventory	2,550	2,631	2,588	4,287	5,016	2,504
Prepaid Expenses	114.34	135.4	122.16	25.5	355.14	2.96
Other Current Assets	56.71	38.69	150.03	148.65	232.21	971.32
Total Current Assets	43,299	43,627	47,798	48,682	43,927	44,882
Property, Plant & Equipment	14,466	14,847	15,219	15,663	15,867	12,721
Long-Term Investments	4,575	5,389	5,372	3,374	2,882	4,344
Other Intangible Assets	375.08	391.88	447.39	443.92	446.09	465.75
Long-Term Accounts Receivable	-	-	-0	-0	-0	-0
Long-Term Deferred Tax Assets	1,078	1,163	1,051	1,109	764.95	315.01
Other Long-Term Assets	4,682	4,861	4,948	5,035	5,150	5,086
Total Assets	69,475	71,279	74,835	74,307	69,037	67,813
Accounts Payable	1,622	1,444	1,337	2,175	2,491	2,000
Accrued Expenses	592.81	595.79	1,221	1,035	599.46	63.3
Current Portion of Long-Term Debt	545.44	2,182	3,636	2,667	416.62	923.24
Current Portion of Leases	8.19	5.35	6.48	9.41	5.49	35.37
Current Income Taxes Payable	72.51	160.25	425.46	1,052	62.82	1,320
Other Current Liabilities	1,001	1,062	306.61	302.45	246.01	2,016
Total Current Liabilities	3,842	5,449	6,933	7,240	3,822	6,358
Long-Term Debt	-	-	3,636	5,333	8,000	4,417
Long-Term Leases	17.62	2.65	7.12	13.6	-	4.31
Other Long-Term Liabilities	332	329.5	337	335	336.37	275
Total Liabilities	5,784	7,263	12,168	15,003	13,275	12,306
Common Stock	3,965	3,965	3,965	3,965	3,965	3,965
Additional Paid-In Capital	22,365	22,400	22,400	22,365	22,365	22,391
Retained Earnings	39,258	40,222	37,776	34,415	30,870	29,366
Treasury Stock	-1,998	-1,815	-998.09	-998.09	-998.09	-
Comprehensive Income & Other	-0	-857.82	-580.97	-546	-546	-317.71
Total Common Equity	63,590	63,914	62,562	59,200	55,655	55,404
Minority Interest	101.3	102.26	104.85	103.91	107.07	103.12
Shareholders' Equity	63,691	64,016	62,667	59,304	55,762	55,507
Total Liabilities & Equity	69,475	71,279	74,835	74,307	69,037	67,813
Total Debt	571.25	2,190	7,286	8,023	8,422	5,380
Net Cash (Debt)	38,674	37,356	35,548	33,712	27,875	33,762
Net Cash Growth	4.86%	5.09%	5.45%	20.94%	-17.44%	183.43%
Net Cash Per Share	4986.09	4770.04	4530.52	4296.44	3542.09	5085.25
Filing Date Shares Outstanding	7.73	7.75	7.85	7.85	7.85	7.93
Total Common Shares Outstanding	7.73	7.75	7.85	7.85	7.85	7.93
Working Capital	39,457	38,177	40,866	41,442	40,106	38,524
Book Value Per Share	8228.36	8247.04	7973.30	7544.87	7093.03	6987.24
Tangible Book Value	63,215	63,522	62,115	58,756	55,209	54,938
Tangible Book Value Per Share	8179.83	8196.48	7916.28	7488.30	7036.18	6928.50
Land	3,594	3,594	3,479	3,380	3,380	-
Buildings	11,805	11,805	11,805	11,805	11,805	-
Machinery	1,436	1,418	1,339	1,476	1,206	509.63
Construction In Progress	-	-	-	-	-	12,559

Source: S&P Capital IQ. Standard template. Financial Sources.